As of Jun 01
| +0.0025 / +13.44%|
The 1 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +14,118.01% increase from the last price of 0.02.
The current consensus among 1 polled investment analysts is to Hold stock in Rubius Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.